
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Alpha-D-Galactose
Therapeutic Area : Genetic Disease
Study Phase : Phase II
Sponsor : Cerecor
Deal Size : Undisclosed
Deal Type : Collaboration
Details : This trial will study the safety, tolerability, and efficacy of CERC-801 in patients with PGM1-CDG using daily therapeutic doses of CERC-801 in approximately ten patients.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Undisclosed
November 17, 2020
Lead Product(s) : Alpha-D-Galactose
Therapeutic Area : Genetic Disease
Highest Development Status : Phase II
Sponsor : Cerecor
Deal Size : Undisclosed
Deal Type : Collaboration
